DPCD anticorps (N-Term)
Aperçu rapide pour DPCD anticorps (N-Term) (ABIN631571)
Antigène
Voir toutes DPCD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- RP11-529 I10.4 antibody was raised against the N terminal of RP11-529 10.4
-
Purification
- Affinity purified
-
Immunogène
- RP11-529 I10.4 antibody was raised using the N terminal of RP11-529 10.4 corresponding to a region with amino acids MAEEYDEKTSELLVRKWRVKSALGAMGQWQLEVGDPAPLGAGNLGPELIK
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
RP.4 Blocking Peptide, (ABIN5615922), is also available for use as a blocking control in assays to test for specificity of this RP.4 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RP11-520 10.4 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DPCD (Deleted in Primary Ciliary Dyskinesia Homolog (DPCD))
-
Autre désignation
- RP11-529I10.4
-
Sujet
- RP11-529I10.4 (DPCD) belongs to the DPCD family. It may play a role in the formation or function of ciliated cells. Deletion of the DPCD gene may be a cause of primary ciliary dyskinesia (PCD).
-
Poids moléculaire
- 23 kDa (MW of target protein)
Antigène
-